Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression.

Nieuwstraten CE, Dolovich LR.

Ann Pharmacother. 2001 Dec;35(12):1608-13. Review.

PMID:
11793630
2.

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.

Weihs KL, Settle EC Jr, Batey SR, Houser TL, Donahue RM, Ascher JA.

J Clin Psychiatry. 2000 Mar;61(3):196-202.

PMID:
10817105
3.
4.

Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.

Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, VanMeter S, Harriett AE, Wang Y.

J Clin Psychiatry. 2005 Aug;66(8):974-81.

PMID:
16086611
5.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
6.

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.

Stahl SM, Entsuah R, Rudolph RL.

Biol Psychiatry. 2002 Dec 15;52(12):1166-74.

PMID:
12488062
7.

Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.

Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA.

J Clin Psychiatry. 1997 Dec;58(12):532-7.

PMID:
9448656
8.
9.
10.

SSRI versus bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trial.

Grunebaum MF, Keilp JG, Ellis SP, Sudol K, Bauer N, Burke AK, Oquendo MA, Mann JJ.

J Clin Psychiatry. 2013 Sep;74(9):872-9. doi: 10.4088/JCP.12m08000.

11.

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.

Coleman CC, King BR, Bolden-Watson C, Book MJ, Segraves RT, Richard N, Ascher J, Batey S, Jamerson B, Metz A.

Clin Ther. 2001 Jul;23(7):1040-58.

PMID:
11519769
12.

Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC.

J Clin Psychiatry. 2001 Mar;62(3):185-90.

PMID:
11305705
13.

Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions.

Papakostas GI, Kornstein SG, Clayton AH, Soares CN, Hallett LA, Krishen A, Tucker VL.

Int Clin Psychopharmacol. 2007 Jul;22(4):226-9.

PMID:
17519646
14.
15.

Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.

Safarinejad MR.

J Psychopharmacol. 2011 Mar;25(3):370-8. doi: 10.1177/0269881109351966. Epub 2010 Jan 15.

PMID:
20080928
16.

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.

Croft H, Settle E Jr, Houser T, Batey SR, Donahue RM, Ascher JA.

Clin Ther. 1999 Apr;21(4):643-58.

PMID:
10363731
17.

Fluoxetine versus other types of pharmacotherapy for depression.

Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2013 Jul 17;(7):CD004185. Review.

PMID:
24353997
18.

Selective serotonin reuptake inhibitors for fibromyalgia syndrome.

Riera R.

Sao Paulo Med J. 2015 Sep-Oct;133(5):454. doi: 10.1590/1516-3180.20151335T1.

19.

A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.

DeBattista C, Solvason HB, Poirier J, Kendrick E, Schatzberg AF.

J Clin Psychopharmacol. 2003 Feb;23(1):27-30.

PMID:
12544372

Supplemental Content

Support Center